Vaccinex Statistics

Total Valuation

Vaccinex has a market cap or net worth of $10.58 million. The enterprise value is $7.70 million.

Market Cap	10.58M
Enterprise Value	7.70M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Vaccinex has 1.58 million shares outstanding. The number of shares has increased by 458.78% in one year.

Shares Outstanding	1.58M
Shares Change (YoY)	+458.78%
Shares Change (QoQ)	+186.26%
Owned by Insiders (%)	6.81%
Owned by Institutions (%)	50.42%
Float	612,332

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	85.35
Forward PS	n/a
PB Ratio	3.99
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	62.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.07.

Current Ratio	1.52
Quick Ratio	1.24
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-461.20%
Return on Capital (ROIC)	-808.91%
Revenue Per Employee	$3,351
Profits Per Employee	-$518,541
Employee Count	37
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.00% in the last 52 weeks. The beta is 0.86, so Vaccinex's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-91.00%
50-Day Moving Average	6.03
200-Day Moving Average	9.83
Relative Strength Index (RSI)	55.20
Average Volume (20 Days)	16,421

Short Selling Information

The latest short interest is 20,133, so 1.27% of the outstanding shares have been sold short.

Short Interest	20,133
Short Previous Month	9,153
Short % of Shares Out	1.27%
Short % of Float	3.29%
Short Ratio (days to cover)	0.61

Income Statement

In the last 12 months, Vaccinex had revenue of $124,000 and -$19.19 million in losses. Loss per share was -$27.16.

Revenue	124,000
Gross Profit	124,000
Operating Income	-22.97M
Pretax Income	-19.19M
Net Income	-19.19M
EBITDA	-19.07M
EBIT	-19.19M
Loss Per Share	-$27.16

Full Income Statement

Balance Sheet

The company has $3.07 million in cash and $185,000 in debt, giving a net cash position of $2.88 million or $1.82 per share.

Cash & Cash Equivalents	3.07M
Total Debt	185,000
Net Cash	2.88M
Net Cash Per Share	$1.82
Equity (Book Value)	2.66M
Book Value Per Share	1.68
Working Capital	2.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.83 million and capital expenditures -$18,000, giving a free cash flow of -$16.84 million.

Operating Cash Flow	-16.83M
Capital Expenditures	-18,000
Free Cash Flow	-16.84M
FCF Per Share	-$12.69

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -18,526.61% and -15,472.58%.

Gross Margin	100.00%
Operating Margin	-18,526.61%
Pretax Margin	-15,472.58%
Profit Margin	-15,472.58%
EBITDA Margin	-15,379.84%
EBIT Margin	-15,472.58%
FCF Margin	-13,583.87%

Dividends & Yields

Vaccinex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-458.78%
Shareholder Yield	-458.78%
Earnings Yield	-181.29%
FCF Yield	-159.16%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 20, 2024. It was a reverse split with a ratio of 1:14.

Last Split Date	Feb 20, 2024
Split Type	Reverse
Split Ratio	1:14

Scores

Vaccinex has an Altman Z-Score of -72.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-72.17
Piotroski F-Score	2